HSS Medical Supply will distribute Abbott's ID NOW rapid molecular testing platform, expanding point-of-care diagnostics.

HSS Medical Supply, a family-owned and operated medical distribution company, announced a new vendor agreement with Abbott Laboratories ( ABT) to add Abbott's ID NOW, a rapid molecular testing ...

Boost ROI through AI-enabled rapid testing, point-of-care innovation, clinical and food-safety expansion, and tariff-resilient supply chains.Dublin, Nov. 02, 2026 (GLOBE NEWSWIRE) -- "Automated and ...

One of the fastest-growing healthcare suppliers, HSS Medical Supply, announced a new vendor agreement with Abbott. The family-owned distribution company now includes Abbott's ID NOW™, a rapid ...

A computer vision algorithm reads BinaxNOW COVID-19 rapid antigen test images, estimates viral load against PCR cycle ...

Fintel reports that on October 27, 2026, Argus Research downgraded their outlook for Abbott Laboratories (SNSE:ABT) from Buy ...

Some of the social media posts paid for by Gina Hinojosa’s campaign for Texas governor don’t include a disclosure, despite a state regulation that likely requires it.

Dr. Rick Baehner, Abbott’s chief medical officer for precision oncology, spoke to MedTech Dive about how the new version of the Oncodetect test performs and the market it addresses.

Abbott has launched an updated version of its Oncodetect blood test, which helps clinicians determine whether cancer remains in patients with solid tumors ...

Abbott’s next-gen Oncodetect molecular residual disease (MRD) test detects traces of circulating tumor DNA in a patient’s ...

Abbott Laboratories remains a Buy, driven by robust device and diagnostics growth and the strategic spin-off of its Nutrition ...